ArticleMolecular psychiatry2026
Effects of family genetic risk scores and environmental factors on risk of schizophrenia and bipolar disorder.
Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Both genetic and environmental risk factors contribute to the development of schizophrenia (SCZ) and bipolar disorder (BD), but simultaneous investigation of how these factors influence risk has not yet been comprehensively examined in a large population. Therefore, we aimed to investigate and quantify how a multi-generational index of aggregated genetic risk (family genetic risk scores, FGRS) and environmental exposures jointly contribute to risk for SCZ and BD, and whether these relationships differ between the disorders. We conducted a Swedish register-based matched nested case-control study with 3057 SCZ and 15,029 BD cases diagnosed 1988-2013. We used conditional logistic regression to determine individual and joint effects of established environmental risk factors including adverse childhood experiences (ACEs), substance use, adverse perinatal factors, childhood infections, urban birth and longest residence, and FGRS (quintiles) for SCZ and BD and risk of SCZ/BD. We also estimated population attributable fractions (PAFs) for environmental exposures. FGRS were associated with incremental increases in SCZ and BD, with highest risk observed for the highest quintile (SCZ IRR 9.63, 95% CI 7.17-12.94; BD IRR 6.30, 95% CI 5.80-6.84). FGRS and most environmental exposures were independently associated with risk of SCZ and BD. The greatest PAFs were observed for substance use (SCZ 18.3%; BD 13.2%) and ACEs (SCZ 14.1%; BD 19.8%). FGRS are associated with increased risk for SCZ and BD and were largely independent from environmental risk factors. Potentially modifiable factors, ACEs and substance use, accounted for a moderate proportion of all cases and were particularly impactful for BD (PAF 19.8, 95% CI 18.4, 21.2) and SCZ (PAF 18.3, 95% CI 17.6-19.0), respectively.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.